Turning Point Therapeutics, Inc. Shareholders' Equity
Turning Point Therapeutics, Inc. had Shareholders' Equity of $793.02 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-08-08
- 2022-06-30: Stockholders' Equity Attributable to Parent $793.02M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $891.35M.
- 2021-12-31: Stockholders' Equity Attributable to Parent $954.42M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $1.02B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-06-30 | $793.02M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $891.35M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $954.42M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $1.02B 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.07B 10-Q · filed 2022-08-08 |
| 2021-03-31 | $1.10B 10-Q · filed 2022-08-08 |
| 2020-12-31 | $1.11B 10-Q · filed 2022-08-08 |
| 2020-09-30 | $701.59M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $710.83M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $381.71M 10-Q · filed 2021-11-09 |
| 2019-12-31 | $404.35M 10-K · filed 2022-02-28 |
| 2019-09-30 | $420.52M 10-Q · filed 2020-11-12 |
| 2019-06-30 | $247.91M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$60.01M 10-Q · filed 2020-11-12 |
| 2018-12-31 | -$48.41M 10-K · filed 2022-02-28 |
| 2018-09-30 | -$40.14M 10-Q · filed 2019-11-04 |
| 2018-06-30 | -$34.35M 10-Q · filed 2019-11-04 |
| 2018-03-31 | -$29.49M 10-Q · filed 2019-11-04 |
| 2017-12-31 | -$24.84M 10-K · filed 2021-03-01 |
| 2016-12-31 | -$8.66M 10-K · filed 2020-03-18 |